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Dementia:	a	growing	problem	for	
older	people	with	diabetes?
D iabetes mellitus is common in older populations, as 
discussed in a previous article 
in this series (Phillips and 
Phillips, 2011). In part, this is 
due to much improved 
outcomes in diabetes, with 
better risk management 
strategies (Hawthorne, 2009). 
The aim of this article is to 
investigate the impact and 
risk of diabetes in, specifically, 
vulnerable older people, 
particularly those developing 
cognitive impairment leading 
to dementia. 
The ethical aspects of 
health-care decision making 
for people with dementia can 
be challenging (Beauchamp 
and Childress, 2009). Loss of 
memory and cognitive 
dysfunction can make it 
difficult for people to take a 
full role in decisions about 
their care, and requires 
intervention and support from 
carers (often a close relative).
The desire to both avoid 
harm and achieve national 
blood glucose targets can be 
difficult to achieve in the care 
of some older people with 
diabetes, as Phillips and 
Phillips (2011) explained in a 
previous article. Cognitive 
impairment such as dementia 
makes treatment decisions in 
diabetes even more complex. 
Practices nurses are at the 
forefront of providing 
individualized diabetes care in 
conjunction with multi-
disciplinary teams including 
social services, home carers, 
residential and nursing home 
carers, community nurses, 
partners and community 
mental health teams. This 
article explores the questions 
arising in such care, and uses 
the experience of Barry as an 
example (Case Study 1).
Dementia:	definitions		
Raffaitin et al (2009) 
described dementia as the 
most severe pathological form 
of brain ageing. The term 
‘dementia’ is used to describe 
a variety of cognitive and 
behavioural symptoms 
including memory loss and 
disturbance; impairment of 
abstract thinking, reasoning 
and judgment; mood and 
personality changes; and 
aphasia, apraxia or agnosia. 
All types of dementia are 
progressive; the mental and 
physical symptoms worsen 
over time. There are four 
main types of dementia, each 
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with some differences in 
symptoms and pathophysiology 
(Burns et al, 2005):
 ➤Alzheimer’s disease (the 
most common form of 
dementia)
 ➤Vascular dementia (mostly 
affecting people with 
diabetes due to the 
association with 
hypertension)
 ➤ Fronto-temporal dementia
 ➤ Lewy body dementia.
Mild cognitive impairment 
is a precursor for dementia in 
some people. 
Epidemiology
Dementia affects about 1 in 
100 of the UK population and 
its incidence increases with 
age (Knapp and Prince, 2007).
Dementia affects more 
women than men to a ratio of 
2:3 (Knapp and Prince, 2007; 
Cukierman-Yaffe et al, 2009); 
but as women outlive men, 
this may not be unexpected.
There is some evidence of a 
genetic role in the development 
of dementia (Graham et al, 
1999) but many environmental 
factors have also been 
implicated. 
The onset of dementia is 
progressive and usually 
gradual (although cases or 
early onset can be more rapid). 
Eventually the person affected 
will struggle with everyday 
tasks and become totally 
dependent on others for all 
their activities of daily living.
Prevalence	of	
dementia
Current estimates are that 
there are over 820 000 people 
in the UK with some form of 
dementia, with Alzheimer’s 
disease affecting up to 60% 
of this group (Health 
Economics Research Centre, 
2010). 
The Alzheimer’s Society 
(2011) estimates that, in 
people over 65 years of age,  
1 in 14 is affected by 
Alzheimer’s disease. The risk 
increases with age, and people 
over 80 years of age are 
thought to have a 1 in 6 
chance of developing the 
condition (Alzheimer’s Society, 
2011). 
The prevalence of dementia 
is predicted to rise to over 
1 million people by 2025, an 
increase of 38% over the next 
15 years (O’Connor, 2009). 
Furthermore, dementia has 
been estimated to cost the 
economy £23 billion in 
treatment and care (Health 
Economics Research Centre, 
2010).
Dementia is one of the most 
common and devastating 
conditions of later life; with 
about 4.6 million new cases 
occurring worldwide annually 
(Ferri et al, 2005). The 
number of people with 
dementia is predicted to 
double every 20 years, to 
reach an estimated 
81.1 million people 
worldwide by 2040 (Ferri et 
al, 2005).
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Type	2	diabetes	and	
dementia	progression
Type 2 diabetes is associated 
with increased cognitive 
impairment and dementia 
(Velayudhan et al, 2010). 
Strachan (2010) suggested 
that very high blood glucose 
concentrations are associated 
with poor memory, ill health 
and mood changes. This could 
be the result of alterations in 
cerebral blood flow causing 
osmotic changes in neurones, 
as a result of cerebral micro-
vascular disease. Indeed, 
disease and stroke; these can 
also cause cognitive 
impairment owing to 
ischaemic brain damage 
(Bruce et al, 2008). 
Furthermore, diabetes is 
associated with damage to the 
central nervous system (CNS) 
and cognitive deficits; the 
CNS deficits range from 
moderate to severe depending 
on the quality of glycaemic 
control (Moireria et al, 2007). 
Insulin affects several brain 
functions including cognition 
and memory. Insulin 
diabetic retinopathy is a 
surrogate marker of cerebral 
microvascular disease, and 
people with retinopathy are 
likely to have a longer 
duration of diabetes and also 
be hypertensive (Gillibrand 
and Holdich, 2010). 
The most common form of 
dementia affecting people 
with diabetes is vascular 
dementia (Jolley, 2009). The 
reason for this is thought to 
be the vascular complications 
of diabetes. Diabetes is a risk 
factor for cerebrovascular 
resistance, accumulation of 
advanced glycation end-
products (AGEs), and/or 
changes in cerebral signalling 
have been shown to be 
associated with development 
of earlier-onset Alzheimer’s 
disease (Moireria et al, 2007; 
Bruce et al, 2008). 
Hypertension in middle age 
also increases the risk of 
developing dementia (Qiu et 
al, 2005), as does obesity 
(Gorospe and Dave, 2007) 
and dyslipidaemia (Reitz et al, 
2004); all of which are 
independent modifiable risk 
factors for diabetes, vascular 
disease and dementia.
Diabetes	treatments
Planning of treatment and 
care for people with type 1 
and type 2 diabetes is an 
important area for practice 
nurses and GPs. In particular, 
with declining cognitive 
function, safety is of primary 
concern. Using a partnership 
approach in considering 
treatment options and making 
alternative choices proactively 
can help maintain an 
individual’s independence for 
longer. 
When cognitive functioning 
declines, routine and 
familiarity for the person 
affected is crucial. This is of 
consideration when care 
planning with someone using 
insulin, who may find a twice-
daily regimen more suitable 
than a multi-dose regimen, 
where forgetting a dose or 
several doses is increasingly 
likely. New insulin safety 
guidance was released by the 
National Patient Safety 
Agency (2010) (Case Study 1). 
The association between 
type 1 and 2 diabetes, 
hypoglycaemia and cognitive 
impairment has been 
highlighted by Strachan 
Barry is a 74-year-old retired engineer. He 
has type 1 diabetes and has a long history of 
good control using a multiple-dose injection 
regimen. More recently Barry’s partner has 
noticed he has been becoming increasingly 
short tempered and sometimes forgets 
commitments that they have made together. 
Barry’s partner discloses her concerns to 
her practice nurse and together they agree 
to approach this when Barry has his annual 
review the following week. One concern the 
practice nurse has is Barry’s fierce 
independence concerning his diabetes and 
insulin injections. He will not discuss these 
with his partner as he sees his diabetes as 
his concern only. 
At his annual review the practice nurse 
engages Barry in discussing an unrelated 
diabetes issue and notices he becomes quite 
animated. When she tries to relate this to 
his diabetes control, she finds that he is 
evasive and not able to recount his 
knowledge of his insulin doses or any 
hypoglycaemic episodes that his partner 
previously reported to her. This concerns 
the nurse, and she arranges to review him 
in a week’s time to undertake a review of 
his injection technique and to undertake a 
Mini Mental State Examination (MMSE). 
She also asks Barry to record his blood 
glucose tests and insulin doses over the next 
week to review with him when they meet. 
Barry’s partner accompanies him to his 
appointment, but he does not have any 
blood glucose levels or insulin doses 
recorded and appears to not remember this 
was previously discussed with him. When 
reviewing his injection technique, the nurse 
has concerns as Barry’s technique is 
uncertain and unsteady. His practice nurse 
is concerned this is unsafe. On completion 
of the MMSE, Barry has a score of 21 out 
of 30, which indicates early stage dementia 
(NICE, 2011). Barry asks what his score 
means and the practice nurse discusses the 
possible implications with him. 
Barry reacts with relief and expresses 
emotion, as he has been hiding his 
symptoms from his partner for sometime, 
not wanting to bother her. He is keen to be 
helped and together the practice nurse, 
Barry and his partner discuss the options 
available to them.
The high priority concerns are to refer 
Barry to his GP for further assessment and 
investigation, and to immediately ensure 
Barry’s safety using insulin. The practice 
nurse, together with Barry and his partner, 
discuss a change in Barry’s insulin regimen 
to make it easier for him to manage. The 
practice nurse also suggests that the 
community nursing team help Barry in the 
short term in the transition to this new 
regimen. Barry agrees to this.
CASE	STUDY	1
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(2011). People with cognitive 
impairment find it more 
difficult to self-manage their 
diabetes, making evaluating 
and deciding from the 
treatment choices available to 
them more difficult; if 
treatment is inappropriate as 
a result, this may increase the 
risk of hypoglycaemia. 
In turn, hypoglaecaemia 
increases the risk of cognitive 
dysfunction and physical 
disability, such as foot 
complications, which can, in 
turn, cause people to fall and 
sustain fractures (Mayne et  
al, 2010). 
The combined consequences 
of diabetes and cognitive 
impairment therefore can have 
a substantial impact on an 
individual’s quality of life, 
leading to loss of 
independence, increasing the 
fear of living alone and 
increasing dependence and 
demands on carers. Addressing 
such effects are of greater 
concern in older people living 
with diabetes than vascular 
risk reduction alone.
Triple	jeopardy
There is also an increased risk 
for people with learning 
difficulties such as Down’s 
syndrome developing both 
type 1 and type 2 diabetes 
(NHS Choices, 2011). This 
raised risk is compounded by 
the fact that people with 
Down’s syndrome who live to 
35 years have a 15–40% 
chance of developing 
Alzheimer’s disease; the same 
risk as that of the population 
in general at 75 years of age 
(Holland and Benton, 2004). 
This triple jeopardy needs to 
be recognized by practitioners 
in their annual screening of 
individuals and appropriate 
risk management strategies 
identified. However, the 
assessment and diagnosis of 
Alzheimer’s disease in people 
with Down’s syndrome is 
difficult to determine owing 
to the masking of symptoms 
by the complex nature of 
Down’s syndrome 
presentation (Stanton and 
Coetzee, 2004). 
Early	diagnosis
Cognitive assessment is 
recommended by the National 
Institute for Health and 
Clinical Excellence (NICE) 
(2011) to ensure early 
diagnosis of dementia. The 
Quality and Outcomes 
Framework (QOF) 
recommends that each general 
practice maintains a register 
of people diagnosed with 
dementia (British Medical 
Association and NHS 
Employers, 2011). Standard 
assessment tools that may be 
used in general practice are 
the Mini Mental State 
Examination (MMSE), the Six 
Item Cognitive Impairment 
Test (6-CIT), the General 
Practitioner Assessment of 
Cognition (GPCOG) and the 
7-minute screen (NICE, 2011). 
A new online screening test 
advocated by Age UK and the 
Alzheimer’s Society for the 
assessment of cognitive 
function has been launched 
for individuals aged  
50–70 years. It can be 
accessed free online at www.
foodforthebrain.org. 
Recognition	of	signs	
and	symptoms
Declining cognitive function 
in diabetes can cause 
significant difficulties in self-
care. People may not manage 
their tablet or insulin 
regimens correctly or may fail 
to recognize the need to eat in 
the later stages of dementia.
Early symptoms of 
dementia can include memory 
loss which makes any new 
treatment decision about 
diabetes control difficult to 
communicate, understand and 
maintain. Language 
impairment, disorientation 
and changes in personality 
can occur, which are also 
symptoms of hypoglycaemia 
(Sinclair et al, 2010). 
Difficulties with activities of 
daily living manifest, which 
can include forgetting to take 
medications and forgetting to 
eat regular meals. This can 
also promote hypo- and 
hyperglycaemia (Sinclair et al, 
2010). Self-neglect can occur 
and individuals can become 
depressed and act ‘out of 
character’, which can indicate 
possible hypo- or 
hyperglycaemia. 
Discomfort or pain may be 
difficult to express for people 
with cognitive impairment 
and carers need to be mindful 
of this and be extra vigilant to 
identify vascular changes or 
accidental injuries, in 
particular, in the feet.
Sinclair et al (2010) 
recognized the important role 
carers have in ensuring the 
individual affected is having 
their needs catered for, and 
also to ensure that diabetes 
management is maintained to 
keep the person well.
Practical decision making to 
reduce the incidence of 
hypoglycaemia and to reduce 
complicated treatment 
regimens might be confusing 
to the individual and the 
relaxing of haemoglobin A1c 
(HbA1c) targets is to be 
advised to try to minimize the 
risk of hypoglycaemia 
(Phillips and Phillips, 2011). 
Practice nurses may be the 
only professional contact 
someone with memory 
problems sees, so memory 
strategies and aids that people 
can use, e.g. diaries, text 
messaging services, phone 
alerts and Post-it notes, can 
Table	1.	Dementia	support	organizations
Age UK National charity formed through the merger of Age Concern and 
Help the Aged offering advice on benefits, care and age discrimination
www.ageuk.org.uk
Alzheimer’s Society UK charity supporting people with dementia, their families and carers www.alzheimers.org.
uk
Atdementia Provides information on assistive technology for people with dementia www.atdementia.org.
uk
Dementia Cafe Offers information on dementia including news, training, forums, chat 
rooms, downloads, memory games, telephone support and a dementia 
café for people with dementia and their carers
www.dementiacafe.
co.uk
Dementia UK National charity committed to improving quality of life for all people 
affected by dementia. Supports Admiral Nurses, the specialist dementia 
nursing service
www.dementiauk.org
Diabetes UK National charity for people with diabetes, providing advice and 
support on many aspects of living with diabetes
www.diabetes.org.uk
Practice Nursing 2011, Vol 22, No 10 531
 
help remind the person to 
take their medication, 
especially in the early stages 
so that the individual can 
remain independent for as 
long as possible.
People with dementia may 
exhibit aggressive behaviour, 
restlessness, wandering and 
eating problems, all of which 
might be attributed to hypo-
glycaemia. Incontinence is 
also a common symptom of 
hyperglycaemia. Usually 
individuals require nursing 
home care in the latter stages 
of dementia.
Sources	of	support
Both diabetes and dementia 
are growing problems in the 
older population. Sources of 
support that may be available 
locally include memory 
assessment services, usually 
provided by a single 
assessment clinic or by 
community mental health 
teams (NICE, 2010). Practice 
nurses need to be aware of 
these services and also of the 
help that may be provided 
through other organizations 
(Table 1). 
Conclusions
As practice nurses have such a 
unique role, often being the 
first point of care for people 
with diabetes and their 
families, their distinctive 
relationship can allow them 
to be curious and ask 
appropriate questions when 
reviewing people with 
diabetes. It is important to 
understand the association 
between dementia and 
diabetes, and how cognitive 
impairment can undermine 
the vigilant self-care required 
to manage diabetes well. With 
that understanding, 
assessment to diagnose 
cognitive decline and to 
introduce supportive services 
can be provided.
Having honest 
conversations, with 
individuals like Barry and his 
partner can help promote the 
aims of the National 
Dementia Strategy, which 
highlighted the importance of 
early diagnosis to enable 
individuals and their families 
respond effectively to the 
progress of their dementia 
(Department of Health, 2009; 
Downs et al, 2002).
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Key PointS
 ➤ There are an estimated 
820 000 people in the UK 
with some form of 
dementia
 ➤ Type 2 diabetes is 
associated with increased 
cognitive impairment and 
dementia
 ➤ Planning treatment and 
care for people with 
diabetes and cognitive 
impairment can help 
maintain their independance 
for longer
 ➤ Cognitive assessment is 
important to ensure early 
diagnosis
